Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001195055-10-000001)

Filing Details

Accession Number:: 0001195055-10-000001
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-07-29 13:00:00
Reporting Period:: 2010-07-27

Filing Date:: 2010-07-29
Accepted Time:: 2010-07-29 17:38:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
887708	Caraco Pharmaceutical Laboratories Ltd	CPD	Pharmaceutical Preparations (2834)	382505723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1195055	N Jitendra Doshi	1150 Elijah Mccoy Drive Detroit MI 48202	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-07-27	10,246	$6.04	38,254	No	4	S	Direct
Common Stock	Disposition	2010-07-27	400	$6.05	37,854	No	4	S	Direct
Common Stock	Disposition	2010-07-27	600	$6.06	37,254	No	4	S	Direct
Common Stock	Disposition	2010-07-27	854	$6.07	36,400	No	4	S	Direct
Common Stock	Disposition	2010-07-28	5,700	$6.04	30,700	No	4	S	Direct
Common Stock	Disposition	2010-07-29	1,000	$6.04	29,700	No	4	S	Direct
Common Stock	Disposition	2010-07-29	300	$6.05	29,400	No	4	S	Direct
Common Stock	Disposition	2010-07-29	1,200	$6.06	28,200	No	4	S	Direct
Common Stock	Disposition	2010-07-29	400	$6.07	27,800	No	4	S	Direct
Common Stock	Disposition	2010-07-29	300	$6.08	27,500	No	4	S	Direct
Common Stock	Disposition	2010-07-29	100	$6.10	27,400	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	26,500	Indirect	By wife

Footnotes

On June 11, 2010, the reporting person entered into a Rule 10b-5 trading plan to sell up to 45,000 shares of common stock for estate and tax planning purposes. The reported sales were effected pursuant to such Rule 10b5-1 trading plan.